372594940	372594940	CD	B-NP	O
|	|	NN	I-NP	O
FIHMC	FIHMC	NN	I-NP	O
|	|	NN	I-NP	O
23656372	23656372	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3821265	3821265	CD	B-NP	O
|	|	CC	I-NP	O
1/22/2007	1/22/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/18/2007	10/18/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/3/2007	11/3/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
CRISTOBAL	CRISTOBAL	NNP	B-NP	O
,	,	,	O	O
DAMION	DAMION	NNP	B-NP	O
MD	MD	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
three-vessel	three-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
who	who	WP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
tingling	tingling	NN	I-NP	O
that	that	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
after	after	IN	B-SBAR	O
1	1	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitro	nitro	NN	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
,	,	,	O	O
on	on	IN	B-PP	O
10/18/2007	10/18/2007	CD	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
220s	220s	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
.	.	.	O	O

Called	Call	VBN	B-VP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
told	tell	VBN	I-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
10/18/2007	10/18/2007	CD	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	JJ	I-NP	O
observation	observation	NN	I-NP	O
section	section	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
completed	complete	VBN	I-VP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
undergone	undergo	VBN	I-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
on	on	IN	B-PP	O
7/1/2007	7/1/2007	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
reversible	reversible	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
septal	septal	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
hep	hep	NN	B-NP	B-protein
C	C	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
viral	viral	JJ	I-NP	O
load	load	NN	I-NP	O
after	after	IN	B-PP	O
interferon	interferon	NN	B-NP	B-protein
and	and	CC	O	O
RBV	RBV	NN	B-NP	O
treatment	treatment	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
artery	artery	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
renal	renal	JJ	I-NP	O
stenting	stenting	NN	I-NP	O
,	,	,	O	O
functional	functional	JJ	B-NP	O
quadriplegic	quadriplegic	JJ	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
motor	motor	NN	B-NP	O
vehicle	vehicle	NN	I-NP	O
accident	accident	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
TIA	TIA	NN	B-NP	O
in	in	IN	B-PP	O
1975	1975	CD	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
carotid	carotid	NN	B-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
common	common	JJ	B-NP	O
iliac	iliac	JJ	I-NP	O
artery	artery	NN	I-NP	O
angioplasty	angioplasty	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	O
3-vessel	3-vessel	NN	I-NP	O
11/26	11/26	CD	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
12.5	12.5	CD	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
Prevacid	Prevacid	NN	B-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
,	,	,	O	O
Valium	Valium	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Baclofen	Baclofen	NN	B-NP	O
and	and	CC	I-NP	O
Bactrim	Bactrim	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NNP	B-NP	O
,	,	,	O	O
vital	vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Soft	Soft	RB	B-ADVP	O
,	,	,	O	O
nontender	nontender	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
68-year-old	68-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
three-vessel	three-vessel	JJ	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
workup	workup	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
exercise	exercise	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
three-vessel	three-vessel	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
and	and	CC	I-NP	O
LAD	LAD	NN	I-NP	O
.	.	.	O	O

Proximal	Proximal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
to	to	TO	B-PP	O
diagonals	diagonal	NNS	B-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
bypassed	bypass	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
decision	decision	NN	I-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
team	team	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
referring	refer	VBG	I-NP	O
physician	physician	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
controlling	control	VBG	B-VP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
return	return	NN	I-NP	O
for	for	IN	B-PP	O
repeat	repeat	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
PCI	PCI	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
protected	protect	VBN	I-NP	O
left	leave	VBD	B-VP	O
main	main	JJ	B-ADJP	O
,	,	,	O	O
approximately	approximately	RB	B-ADVP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
diagonals	diagonal	NNS	I-NP	O
if	if	IN	B-SBAR	O
symptoms	symptom	NNS	B-NP	O
recur	recur	VBP	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	I-NP	O
statin	statin	NN	I-NP	O
,	,	,	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
of	of	IN	B-PP	O
2006	2006	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
preserved	preserve	VBN	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
started	start	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
anomic	anomic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
the	the	DT	B-NP	O
fludrocortisone	fludrocortisone	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
by	by	IN	B-PP	O
adding	add	VBG	B-VP	O
lisinopril	lisinopril	NN	B-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
Prevacid	Prevacid	NN	I-NP	O
for	for	IN	B-PP	O
GERD	GERD	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
for	for	IN	B-PP	O
neuropathic	neuropathic	JJ	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Psych	Psych	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
slightly	slightly	RB	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
sundowning	sundowne	VBG	B-VP	O
that	that	IN	B-SBAR	O
worsened	worsen	VBN	B-VP	O
after	after	IN	B-SBAR	O
he	he	PRP	B-NP	O
got	get	VBD	B-VP	O
Ambien	Ambien	NNP	B-NP	O
for	for	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
.	.	.	O	O

Per	Per	IN	B-PP	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
confusion	confusion	NN	B-NP	O
and	and	CC	I-NP	O
paranoia	paranoia	NN	I-NP	O
during	during	IN	B-PP	O
prior	prior	JJ	B-NP	O
hospitalizations	hospitalization	NNS	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
but	but	CC	O	O
exhibited	exhibit	VBD	B-VP	O
paranoid	paranoid	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	O
and	and	CC	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
infectious	infectious	JJ	B-NP	O
process	process	NN	I-NP	O
actually	actually	RB	B-ADVP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
his	his	PRP$	B-NP	O
confusion	confusion	NN	I-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Seroquel	Seroquel	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
nightly	nightly	RB	B-ADVP	O
p.r.n.	p.r.n.	RB	I-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
short-term	short-term	NN	I-NP	O
for	for	IN	B-PP	O
sundowning	sundowne	VBG	B-VP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
pretreated	pretreate	VBN	I-VP	O
with	with	IN	B-PP	O
Mucomyst	Mucomyst	NN	B-NP	O
and	and	CC	I-NP	O
bicarbonate	bicarbonate	NN	I-NP	O
pre	pre	NN	I-NP	O
and	and	CC	O	O
post	post	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
were	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
code	code	NN	I-NP	O
status	status	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
81	81	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
t.i.d.	t.i.d.	FW	I-ADVP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
inhaler	inhal	JJR	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
Prevacid	Prevacid	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Toprol-XL	Toprol-XL	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
MiraLax	MiraLax	NNP	B-NP	O
17	17	CD	I-NP	O
grams	gram	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Seroquel	Seroquel	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
bedtime	bedtime	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
agitation	agitation	NN	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
titrate	titrate	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Optimize	Optimize	VB	B-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
diagnostic	diagnostic	JJ	B-NP	O
results	result	NNS	I-NP	O
showed	show	VBD	B-VP	O
3-vessel	3-vessel	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
patent	patent	NN	B-NP	O
grafts	graft	NNS	I-NP	O
,	,	,	O	O
proximal	proximal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
two	two	CD	B-NP	O
diagonals	diagonal	NNS	I-NP	O
are	be	VBP	B-VP	O
not	not	RB	I-VP	O
bypassed	bypass	VBN	I-VP	O
.	.	.	O	O

Decision	Decision	NNP	B-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
experience	experience	VB	I-VP	O
symptoms	symptom	NNS	B-NP	O
,	,	,	O	O
further	further	JJ	B-NP	O
consideration	consideration	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
and	and	CC	I-NP	O
PCI	PCI	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
blurry	blurry	JJ	I-NP	O
vision	vision	NN	I-NP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
;	;	:	O	O
we	we	PRP	B-NP	O
recommend	recommend	VBP	B-VP	O
further	further	RBR	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
ophthalmology	ophthalmology	NN	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	B-DNA
31	31	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.1	1.1	CD	I-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
139	139	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.4	4.4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
102	102	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
25	25	CD	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
9.7	9.7	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
6	6	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
39.3	39.3	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
212	212	CD	B-NP	I-protein
,	,	,	O	O
normal	normal	JJ	B-NP	O
differential	differential	NN	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
1.1	1.1	CD	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-8567098	3-8567098	CD	B-NP	O
IFFocus	IFFocus	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
FENISON	FENISON	NNP	B-NP	O
,	,	,	O	O
WILFREDO	WILFREDO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HANSTEEN	HANSTEEN	NNP	B-NP	O
,	,	,	O	O
RENATO	RENATO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
9691770	9691770	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/19/07	2/19/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/19/07	2/19/07	CD	B-NP	O

